Fluvoxamine and Certoparin: Interaction Details

Brand names
Fluvoxamine
LuvoxLuvox CR
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Certoparin

We don't have a drug information page for Certoparin yet. Have a question about Certoparin? Ask a pharmacist, free →

What Happens When You Take Fluvoxamine With Certoparin

What can happen when they are taken together (rated Major)

An increased risk of bleeding

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

release , a process that plays a role in maintaining hemostasis. Case-control and cohort studies have linked the combined use of and with a higher risk of bleeding.125

The reported bleeding events include epistaxis, ecchymosis, hematoma, petechiae, and life-threatening hemorrhages. When SSRIs have been given together with warfarin, changes in anticoagulant effect (among them increased bleeding) have been reported.

In patients who took warfarin and fluvoxaMINE together for 2 weeks, warfarin rose by 98% and prothrombin times were prolonged. FluvoxaMINE seems to inhibit multiple isoenzymes, possibly including and , the isozymes that are responsible for the of warfarin.35

The Fluvoxamine and Certoparin Interaction, Explained

Taking fluvoxamine (Luvox) with certoparin can raise your chance of bleeding. Certoparin is a . Fluvoxamine is an antidepressant that also makes (the cells that help blood clot) work less well. Together, the two can add up. Bleeding might show up as nosebleeds, easy bruising, tiny red spots on the skin, or, rarely, serious bleeding. This usually builds over time rather than right away.

Many people take both safely with a little extra attention. Keep taking both as prescribed, and tell your pharmacist or doctor about any unusual bleeding or bruising. They can monitor you and adjust your treatment if needed.

Fluvoxamine + certoparin (LMWH): increased bleeding risk (major, delayed onset, evidence: probable).

  • Mechanism: effects on hemostasis. deplete , impairing platelet aggregation, which compounds the effect of certoparin. Observational data (case-control, cohort) link plus anticoagulant use to bleeding (epistaxis, ecchymosis, hematoma, petechiae, major ).
  • PK note: fluvoxamine inhibits and and raised warfarin concentrations by 98%, but this PK effect applies to warfarin, not to certoparin, which is not -metabolized. The concern here is .
  • Management: monitor for signs of bleeding, periodically reassess coagulation parameters as clinically appropriate, and adjust the anticoagulant dose accordingly. Counsel patients to report bleeding.

See the 5 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Fluvoxamine and Certoparin Interact

The likely mechanism

effects on hemostasis

In short: Fluvoxamine and certoparin both make bleeding more likely, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Fluvoxamine and Certoparin Interaction

Your care team can usually manage this combination with monitoring and dose tailoring.

  • Keep taking both medicines as prescribed. Do not stop or change either one on your own.
  • Your team may monitor you more closely for signs of bleeding, and your dose may need to be adjusted and individualized.
  • Tell your pharmacist or doctor right away about nosebleeds, unusual bruising, tiny red or purple spots, blood in urine or stool, or any bleeding that is hard to stop.
  • Check with your care team before starting any new medicine, including pain relievers like aspirin or ibuprofen.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Fluvoxamine or Certoparin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

4 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment

    A retrospective cohort study (n=234) found a higher risk of clinically relevant bleeding (hospital admission due to bleeding) in patients taking warfarin for atrial fibrillation who were receiving an at the same time or within 2 weeks after stopping the SSRI. Patients with a mean age of 72 +/- 7 years who received warfarin plus an SSRI (n=117) were matched with randomly selected patients who received warfarin alone (n=117).

    The were FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. In the warfarin plus SSRI group, 9 patients had 11 bleeding episodes over 213.9 treatment years, while in the warfarin-only group, 10 patients had 14 bleeding episodes over 586.4 treatment years.

    The corresponding total bleeding incidences were 51.4 and 23.9 per 1000 treatment years, respectively. Compared with warfarin alone, the hazard ratio for first bleeding during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009).

    The SSRIs implicated in patients who bled during were sertraline or citalopram. Adding an SSRI was not associated with a change in warfarin dose or (p=0.48 and p=0.31 respectively). The findings may be limited by prior bleeding events, unknown patient adherence, and the exclusion from the model of clopidogrel, dipyridamol, , and other than warfarin.2

  2. Report 2 · Study title

    Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins

    A population-based, case-controlled study of new coumarin users (acenocoumarol and phenprocoumon) taking selective reuptake () found an increased risk of hospitalization for non-gastrointestinal bleeding. Drawing on national pharmacy and hospitalization records, researchers in the Netherlands identified 1848 cases admitted for abnormal bleeding and compared them with 5818 control subjects who were also taking coumarins.

    The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients taking SSRIs had a greater risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5), whereas the rate of bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) did not differ significantly.3

  3. Report 3 · Study title

    Interaction of fluvoxamine with warfarin in an elderly woman

    An 80-year-old woman was hospitalized and started on intravenous heparin and oral warfarin because of an embolic stroke secondary to atrial fibrillation and mitral stenosis. Her warfarin dose was maintained at 1 mg daily, with between 2.5 and 3.

    FluvoxaMINE 25 mg daily was started for depression, and 3 days later her warfarin dose was raised to 1.5 mg daily because of worsening left hemiparesis. Three days after that, her INR was 9.96, and a repeat INR to exclude laboratory error was 11.3.

    Warfarin and fluvoxaMINE were discontinued, and fresh frozen plasma was given. Six days later, warfarin was restarted at 1 mg daily, and over 4 days the INR rose to 11.8.

    The elevated INR was attributed to the persisting effect of fluvoxaMINE. She was eventually stabilized on warfarin 1 mg daily with INR values between 2 and 2.5.4

  4. Report 4 · Study title

    Prescribing information: Fluvoxamine maleate oral tablets, fluvoxamine maleate oral tablets

    When fluvoxaMINE maleate (50 mg thrice daily) was given together with warfarin for two weeks, warfarin rose by 98% and prothrombin times were prolonged.1

Fluvoxamine and Certoparin: Common Questions

How serious is the Fluvoxamine and Certoparin interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Fluvoxamine and Certoparin interaction managed?

Your care team can usually manage this combination with monitoring and dose tailoring. Keep taking both medicines as prescribed. Do not stop or change either one on your own. Your team may monitor you more closely for signs of bleeding, and your dose may need to be adjusted and individualized. Tell your pharmacist or doctor right away about nosebleeds, unusual bruising, tiny red or p… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Fluvoxamine and Certoparin Interaction

Ask in your own words about taking Fluvoxamine and Certoparin together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (5)

  1. Product Information: Fluvoxamine maleate oral tablets, fluvoxamine maleate oral tablets. ANI Pharmaceuticals Inc (per FDA), Baudette, MN, 2023. DailyMed
  2. Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. PubMed
  3. Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
  4. Yap KB & Low ST: Interaction of fluvoxamine with warfarin in an elderly woman. Singapore Med J 1999; 40:480-482.
  5. Product Information: LUVOX(R) CR extended-release oral capsules, fluvoxamine maleate extended-release oral capsules. Jazz Pharmaceuticals,Inc, Palo Alto, CA, 2008. DailyMed
Was this write-up helpful?

Other Serious Interactions of Fluvoxamine and Certoparin

Also serious with Fluvoxamine

Also serious with Certoparin

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Fluvoxamine

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks. This interaction.
  • UnspecifiedThe timing of this interaction is not well characterized.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.